Comparison Chart Damora Therapeutics, Inc.
Stocks
DMRA
KYG2646Y1044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 21.61 USD | -1.59% |
|
+0.37% | -6.08% |
| 09-28 | Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing | MT |
| 09-20 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAMORA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -1.59% | +0.37% | -6.08% | +201.82% | -74.12% | 1.33B |  |  | |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
